← All indications
Urinary Incontinence
Involuntary loss of URINE, such as leaking of urine. It is a symptom of various underlying pathological processes. Major types of incontinence include URINARY URGE INCONTINENCE and URINARY STRESS INCONTINENCE.
Subtype terms (2)
More specific conditions that are subtypes of Urinary Incontinence in the MeSH hierarchy.
- Urinary Incontinence, Stress
45 drugs (27 approved, 18 experimental)
- Urinary Incontinence, Urge
28 drugs (23 approved, 5 experimental)
Drugs by status
Approved for this indication (2)
Phase 4 trials (16)
Phase 3 trials (7)
Phase 2 trials (17)
- phenylephrine
- taranabant
- cranberry
- elb245
- cannabidiol
- torsemide
- serlopitant
- uish001
- allogeneic adipose derived mesenchymal stem cell
- autologous skeletal myoblast
- autologous muscle derived stem cells
- sildenafil
- abobotulinumtoxinA
- autologous adipose-derived mesenchymal stem cells
- yiqi suoquan
- litoxetine
- flower pollen
Phase 1 trials (2)
Organizations
Organization Involved with Phase 4 Indications (48)
- Astellas
- Eli Lilly
- Pfizer
- Novartis
- Allergan
- Boehringer Ingelheim
- Steba Biotech S.A.
- Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia
- National Institute on Aging (NIA)
- Aarhus University
- University of Pittsburgh
- Atlantic Health System
- Brown University
- Cairo University
- University of London
- Harvard University
- Georgetown University
- Korea University
- Lund University
- McGill University
- Northwestern University
- Oakland University
- Stanford University
- University of Louisville
- University of Ottawa
- University of South Florida
- University of Alberta
- Tel Aviv University
- Zhengzhou University
- University of California, San Francisco
- +18 more
Organization Involved with Phase 3 Indications (37)
- Merck
- Alza
- Ipsen
- APOGEPHA Arzneimittel GmbH
- Antares Pharma Inc.
- GlaxoSmithKline
- National Institutes of Health (NIH)
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- University of Pennsylvania
- Ain Shams University
- Tzu Chi University
- Case Western Reserve University
- Duke University
- Hormozgan University of Medical Sciences
- Institut Mutualiste Montsouris
- Kaiser Permanente
- Mansoura University
- Loyola University
- Nagoya University
- Oregon Health and Science University
- RTI International
- University of New Mexico
- University of Rochester
- University of Toronto
- University of Zurich
- Mayo Clinic
- Far Eastern Memorial Hospital
- Laval University
- University of California, San Diego
- Vanderbilt University
- +7 more
Organization Involved with Phase 2 Indications (30)
- McNeil
- Sanofi
- American Oriental Bioengineering, Inc.
- Beech Tree Labs, Inc.
- FemmePharma Global Healthcare, Inc.
- GTx
- elbion
- Duramed Research
- Otsuka
- National Cancer Center, Japan
- United States Army
- China Academy of Chinese Medical Sciences
- Johns Hopkins University
- Universidad Autonoma de Madrid
- Wake Forest University
- University of Cologne
- University of Copenhagen
- Belarusian State Medical University
- University of Amsterdam
- UroGen Pharma
- Al Azhar University
- University of Texas, Galveston
- Department of Veteran Affairs
- Norwich Clinical Research Associates Ltd.
- Johnson and Johnson
- People's Liberation Army of China
- Urovant Sciences Ltd.
- Ixaltis SA
- National Academy of Sciences of Belarus
- The state institution N. N. Alexandrov National Cancer Centre of Belarus
Organization Involved with Phase 1 Indications (2)
Organization Involved with Other Experimental Indications (18)
- National Center for Complementary and Integrative Health (NCCIH)
- Barzilai Medical Center
- New England Research Institutes
- Saint Thomas Health Services
- Shinshu University
- Silesian University of Medicine
- Translational Research Informatics Center, Kobe, Hyogo, Japan
- University of Virginia
- Fudan University
- University of California, Irvine
- University of Queensland
- Charles Drew University
- University of Massachusetts
- Vita-Salute University of Milano. Italy
- University of Tasmania
- Seipel Group Pty Ltd
- Endeavour College of Natural Health
- Theralogix LLC